Treatments
Stem cells: what the phrase actually covers
One phrase, many different products. What is approved, what is studied, what is only marketed — and the questions that separate them.
7 min · updated 2026-09-09
Neutral guides, updated as evidence changes
Treatments
One phrase, many different products. What is approved, what is studied, what is only marketed — and the questions that separate them.
Treatments
An acellular category with real laboratory science behind it, no approved product, and no agreed way to measure what is in the vial.
Treatments
Platelet-rich plasma has more human trial data than any other pathway here — and a preparation problem that makes those trials hard to pool.
Treatments
Some peptides are licensed drugs with decades of data. Many sold in wellness settings are neither approved nor studied for the use being sold.
Treatments
Stem cells, exosomes, peptides and PRP are four different things — not four grades of the same thing. A side-by-side orientation.
Evidence
Study types, sample sizes, and the difference between a promising signal and a settled answer — plus the borrowed-citation problem.
Regulatory
The same product can be a licensed procedure in one country and an unapproved drug in another. What that does and does not tell you.
Questions to ask
Direct questions that surface how a provider actually operates, across any pathway.
Conditions
The most common reason people search this field, and the area with the most published data.
Conditions
Pain sources are often multifactorial, which makes single-injection approaches hard to evaluate.
Conditions
InvestigationalA research-first guide to regulatory status, clinical-trial safeguards and questions families can use when evaluating claims.
Medical information disclaimer: these guides are educational and general. They are not medical advice, do not describe your individual case, and should not replace consultation with a qualified healthcare professional.